Publication | Open Access

Effectiveness of adenovirus type 5 vectored and inactivated COVID-19 vaccines against symptomatic COVID-19, COVID-19 pneumonia, and severe COVID-19 caused by the B.1.617.2 (Delta) variant: Evidence from an outbreak in Yunnan, China, 2021

VaccinationVaccine SafetyVirus EpidemiologyEmerging Infectious DiseasesMedicineCovid-19 PandemicImmunologyVirologyAdenovirus Type 5Infection ControlCovid-19 EpidemiologyPublic HealthInactivated Covid-19 VaccinesEpidemiologyCovid-19Covid-19 Pneumonia